Skip to main content
    P

    PharmaCyte Biotech Inc (PMCB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $5.67
    -1.01 (-15.12%)

    Market Cap: $3.77M

    Last updated: Nov 16, 2026 at 4:24 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    64%(7/11)
    Avg Surprise
    -37.06%
    Streak
    1 Q
    Last 12 of 39 reported quarters
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Jul 26
    Reported Sep 14
    $-0.54N/A-N/ABeat--+56.1%
    Apr 26
    Reported Jul 1
    $-0.01N/A-N/ABeat---100.6%
    Jan 26
    Reported Mar 17
    $-0.17N/A-N/ABeat--+61.6%
    Oct 25
    Reported Dec 18
    $-1.24N/A-N/ABeat---220.1%
    Jul 25
    Reported Aug 11
    $-1.23N/A-N/ABeat---164.7%
    Apr 25
    Reported Jul 2
    $1.58N/A-N/ABeat--+599.8%
    Jan 25
    Reported Mar 17
    $-0.44N/A-N/ABeat---525.0%
    Oct 24
    Reported Dec 13
    $-0.39N/A-N/ABeat---50.4%
    Jul 24
    Reported Aug 13
    $1.90$0.00$0.00 - $0.00N/ABeat0
    No revisions (30d)
    +784.0%
    Apr 24
    Reported Jul 29
    $-0.32N/A-N/ABeat---4114.7%
    Jan 24
    Reported Mar 18
    $-0.07$-0.07$-0.07 - $-0.07+0.00%Beat0
    No revisions (30d)
    -74.1%
    Oct 23
    Reported Dec 15
    $-0.26$-0.08$-0.08 - $-0.08-222.00%Miss0
    No revisions (30d)
    -181.8%

    Key Metrics

    Valuation
    P/E Ratio-0.15EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-44.00%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio40.30xQuick Ratio40.30x
    Trading Statistics
    Beta0.77Avg Volume183.76K
    52-Week High$28.6952-Week Low$4.69

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$7.06
    SMA 20$6.73
    SMA 50$7.38
    SMA 200$11.69
    EMA 10$6.85
    EMA 20$6.91
    EMA 50$7.63
    EMA 200$11.26

    MACD

    Line: -0.14Signal: -0.17Hist: 0.03

    ADX

    ADX: 30.6+DI: 8.7-DI: 1.4

    Aroon & PSAR

    Aroon Up96.0
    Aroon Down88.0
    PSAR$0.41

    Bollinger Bands

    Upper Band$7.95
    Lower Band$5.50
    %B Position3641%(Upper)
    Band Width0.07

    RSI (14-Day)

    Neutral
    35.6

    Momentum Oscillators

    Stoch %K1370.9
    Stoch %D2841.5
    Williams %R-31.6
    ROC (10d)-3.8%
    Momentum-0.23
    CCI (20d)278.4
    MFI (14d)50.2

    Volatility Measures

    ATR (14d)$6.04(106.5%)
    StdDev (20d)0.61
    Hist Vol110.3%(High)

    Volume Flow

    VWAP$5.93
    OBV190.3M
    AD Line37.5B
    CMF (20d)186.856

    Volume Metrics

    Avg Vol (20d)191.6K
    Vol Ratio0.3x(Low)
    VWMA (20d)$7.25

    Pivot Points

    R3$9.41
    R2$8.79
    R1$7.74
    Pivot Point$7.12
    S1$6.06
    S2$5.44
    S3$4.39

    Advanced Oscillators

    TSI-7.22
    Ultimate Osc96.3
    KST-39.35

    Financial Data

    QuarterJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023
    Total Revenue$0N/A$0$0$0$0$0$0$0$0$0$0
    Cost of Revenue$0N/A$0$0$0$-905,680$0$0$0$-1,089,934$620,777$229,159
    Gross Profit$0N/A$0$0$0$905,680$0$0$0$1.09M$-620,777$-229,159
    Operating Expenses$1.01M$2.51M$2.12M$1.38M$848,305$1.95M$960,252$1.11M$1.27M$4.26M$1.25M$1.18M
    R&D$60,000$61,946$93,113$141,085$95,157$126,734$118,196$97,470$96,016$94,183$126,732$82,033
    SG&A$946,708$899,882$2.02M$1.23M$753,148$2.24M$842,056$1.01M$1.17M$3.16M$482,675$791,590
    Operating Income$-1,006,708$-2,511,255$-2,118,102$-1,376,051$-848,305$-1,042,663$-960,252$-1,106,060$-1,268,887$-3,166,216$-1,868,946$-1,409,520
    Interest Income$407,162$459,185$230,668$206,387$217,793$229,875$255,692$382,562$547,432$747,098$881,662$894,181
    Interest Expense$4.07M$1.88M$0$6.04M$7.51M$0$2.09M$363,500$0$0$0$0
    Income Before Tax$-5,081,191$-4,393,443$746,860$-7,417,975$-8,360,096$11.75M$-3,045,328$-1,469,560$23.42M$1.35M$-619,537$2.79M
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-5,081,191$-4,393,443$746,860$-7,417,975$-8,360,096$11.75M$-3,045,328$-1,469,560$23.42M$1.35M$-619,537$2.79M
    EBITDA$-5,488,353$-4,852,628$516,192$-7,624,362$-8,577,889$11.52M$-3,301,020$-1,852,122$22.87M$599,603$-1,501,199$1.90M
    EBIT$-5,488,353$-4,852,628$516,192$-7,624,362$-8,577,889$11.52M$-3,301,020$-1,852,122$22.87M$599,603$-1,501,199$1.90M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PMCB

    News

    PMCB Valuation and Fair Value

    P/E
    -0.2x
    Forward P/E
    7.0x
    PEG
    0.0x
    P/B
    0.1x
    See GNG's fair value

    PMCB Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -44.0%

    PMCB Bull Case vs Bear Case

    Bear case

    • PMCB beat EPS estimates in 37.5% of its last 8 reported quarters.

    PMCB Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -56.0%

    PMCB Earnings Date

    PMCB reports Dec 16, 2026. The date is estimated.

    PMCB ETF Holders

    Frequently Asked Questions About PMCB

    When does PMCB report earnings?

    PharmaCyte Biotech Inc (PMCB) is expected to report earnings on Dec 16, 2026.

    Does PMCB pay dividends?

    PharmaCyte Biotech Inc (PMCB) does not currently pay a regular dividend.

    What is PMCB's market cap?

    PharmaCyte Biotech Inc (PMCB) has a market capitalization of $3.77M with a current stock price of $5.67.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.